

Linardic Lab
61 posts

@LinardicLabDuke
Sarcomas are among the most difficult-to-treat cancers in pediatric oncology; we are fighting to find a cure. Acct contact: : @ElizabethM_MS

















🔖Something for your weekend reading list! Identification and targeting of a HES1-YAP1-CDKN1C functional interaction in fusion-negative rhabdomyosarcoma 🔗buff.ly/3TSDBUJ #Rhabdomyosarcoma #YAP1 #SRCST

HOT 🥵 OFF THE PRESS 📄 Check out our newest cover and article in @MolOncology

🫣Our second October issue is online👻 On the cover: Myosin heavy chain in differentiated C2C12 murine myoblasts 👇Take a sneak peek of the latest research 🔓buff.ly/3CYpMx3 #Rhabdomyosarcoma #UrothelialCancer #ExtracellularVesicles #Metabolism #CRCSM #ctDNA




Dr. Ozgun Le Roux and colleagues in the Counter lab discover that different KRAS mutations impart unique quantitative and qualitative signaling outputs, which in turn are preferentially capable of inducing tumor initiation in cell-specific manner. @DukeCancer


